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Recent advances in biomaterial science and tissue engineering technology have greatly spurred the development of regenerative
endodontics. This has led to a paradigm shift in endodontic treatment from simply filling the root canal systems with biologically
inert materials to restoring the infected dental pulp with functional replacement tissues. Currently, cell transplantation has gained
increasing attention as a scientifically valid method for dentin-pulp complex regeneration. This multidisciplinary approach which
involves the interplay of three key elements of tissue engineering—stem cells, scaffolds, and signaling molecules—has produced an
impressive number of favorable outcomes in preclinical animal studies. Nevertheless, many practical hurdles need to be overcome
prior to its application in clinical settings. Apart from the potential health risks of immunological rejection and pathogenic
transmission, the lack of a well-established banking system for the isolation and storage of dental-derived stem cells is the most
pressing issue that awaits resolution and the properties of supportive scaffold materials vary across different studies and remain
inconsistent. This review critically examines the classic triad of tissue engineering utilized in current regenerative endodontics and
summarizes the possible techniques developed for dentin/pulp regeneration.
1. Introduction
Dental pulp is often damaged by infection of cariogenic and
periodontal bacteria, dental trauma, and clinical operative
procedures. A routine clinical treatment for infected or
necrotic pulp tissue is root canal therapy (RCT) which
involves the extirpation of injured pulp and the filling of root
canal systems with bioinert synthetic materials. In spite of
its satisfactory clinical efficacy in infection control and pain
elimination, classical treatmentmodalities like RCTonly seek
to seal the space of root canal system without restoring its
original function. Therefore, various complications such as
tooth fractures and reinfection occur more often in teeth that
have undergone RCT due to their loss of sensory function
and consequent lack of natural defense mechanisms [1].
The history of regenerative endodontics can be traced back
to 1952 when Hermann unprecedentedly utilized calcium
hydroxide for vital pulp therapy [2]. Apexification, a vital
pulp therapy specifically indicated to treat necrotic immature
permanent teeth, has demonstrated its efficacy in promoting
dentinogenesis and apical closure. Nevertheless, apexification
still cannot achieve continual root development or root
reinforcement and is disadvantaged by its high costs and
requirement for time-consuming multiple visits [3]. Such
clinical challenges make it necessary to look at innovative
alternative treatment modalities, with the aim of achieving
partial in situ regeneration of dental pulp tissue or even de
novo synthesis of revitalized whole pulp substitutes [4].
Tissue engineering, an emerging popular domain of
bioscience, is a multidisciplinary research area with the ulti-
mate aim of restoring, maintaining, and regenerating dam-
aged/lost tissue with biologically engineered replacements
through combining the principles of biology, medicine,
and engineering [5]. The advent of tissue engineering has
provided a brand new perspective to revitalize damaged
dentin/pulp tissue using biological approaches other than
traditional remedies. So far, two major strategies have
been applied for dentin-pulp complex regeneration: (1)
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direct implantation of freshly isolated engineered cells along
with/without biodegradable scaffolds and (2) implantation of
preassembled tissue constructs composed of in vitro cultured
cells and scaffolds into target anatomic location [6]. This
reviewpresents an overview of the past achievements, current
advances, and future prospects in the realm of regenerative
endodontics under the purview of tissue engineering. The
various challenges of translating biological concepts into
clinical practice will be critically examined and the focus will
be on potential strategies to overcome currently intractable
hurdles through the development and introduction of clini-
cally feasible protocols.
2. Stem Cells
2.1. Dental Stem Cells. Stem cells are commonly defined
as clonogenic cells that exhibit remarkable long-term self-
renewal and multilineage differentiation capacity. Based on
their distinction in plasticity (the ability of stem cells to
give rise to different specialized cell types), stem cells can
be further subdivided into embryonic stem cells (ESCs)
and postnatal stem cells [7]. Although ESCs have aroused
much interest, their practical application in tissue engineer-
ing and cell-based therapy is limited due to the high risk
of tumorigenicity and ethical and legal issues associated
with their embryonic origin. Currently, increasing research
attention has been diverted to developing tissue regeneration
therapy using postnatal stem cells that have been identified
from various tissues and organs in human body. The term
“mesenchymal stem cells (MSCs)” has been widely used to
broadly describe heterogeneous fibroblastic populations of
cells that possess some multilineage differentiation capacity.
Nevertheless, there are concerns that it might be scientifi-
cally inaccurate to categorize all plastic-adherent cells with
fibroblast-like morphology isolated from bone marrow or
other tissue sources as such, since additional compelling evi-
dence is required to support the “stemness” of unfractionated
plastic-adherent cell populations. “The International Society
for Cellular Therapy” (ISCR) has proposed that plastic-
adherent cells, regardless of their tissue origin, be designated
as “multipotent mesenchymal stromal cells” while the termi-
nology “mesenchymal stem cells” refers to a subpopulation
that fulfill specific stem cell criteria. For both cell populations,
the well-recognized acronym MSCs might be applicable [8].
Dental tissues have also been investigated as potential niches
of MSCs. In accordance with the minimal criteria defined
by the Mesenchymal and Tissue Stem Cell committee of the
ISCR, dental stem cells can be categorized as MSCs based
on their properties of plastic adherence, positive or nega-
tive expression of specific surface antigen markers, in vitro
colony formation, and trilineage mesenchymal differentia-
tion potential [8]. Numerous studies have demonstrated that
dental pulp tissue constitutes an assessable source of postnatal
stem cells that can be harvested from teeth indicated for
extraction or from the “disposable” exfoliated deciduous
teeth with minimal invasiveness on patient donors. Up until
now, various populations of postnatal stem cells have been
isolated fromhealthy pulp tissue or its precursor apical papilla
including dental pulp stem cells (DPSCs), stem cells from
human exfoliated deciduous teeth (SHED), and stem cells
from apical papilla (SCAP), all of which have shown great
potentials for dental tissue engineering particularly in the
field of dentin/pulp tissue regeneration.
2.1.1. Dental Pulp Stem Cells (DPSCs). Gronthos et al. were
the pioneers that identified and characterized a stem cell
population within adult human dental pulp tissue [9, 10].
Isolated from human third molars, DPSCs have demon-
strated high proliferation potential, extensive self-renewal,
and multilineage differentiation capacity under defined
induction conditions in vitro [9–13]. When transplanting
DPSCs with hydroxyapatite/tricalcium phosphate (HA/TCP)
particles into immunocompromised mice, this cell-scaffold
construct produced a dentin-resembled structure lined with
odontoblastic-like cells of donor-origin accompanied with
pulp-like interstitial tissue containing vascular structures [9,
14]. In recent decade, continuous attempted improvements in
the transplantation methods of DPSCs into ectopic animal
models have yielded numerous favorable results supporting
the potential of dental pulp-derived stem cells in regenerating
vascularized dentin/pulp tissue, whether or not incorporat-
ing scaffolds, whether casting scaffolds within pulp chamber
of tooth slices or emptied root canals [9, 14, 15].
2.1.2. Stem Cells from Apical Papilla (SCAP). SCAP were
initially isolated and characterized by Sonoyama et al. from
the apical papilla, an embryonic-like soft tissue located
at the apex of incompletely developed human permanent
teeth [16]. Similar to the multipotency exhibited by DPSCs,
SCAP have demonstrated in vitro osteogenic/odontogenic,
adipogenic, and neurogenic differentiation capacity when
induced by respective stimuli. In vivo studies employing
animal models also demonstrated the odontogenic capacity
of SCAP [16, 17]. Typical dentin structures with pulp-like
tissue were observed after transplanting SCAP with HA/TCP
particles into immunodeficient mice, with the dentinogenic
cells at the transplantation site being verified to be of
human origin. When compared with DPSCs, SCAP exhibit
enhanced proliferation rate and mineralization potential. A
growing body of evidence suggests that SCAP are probably
a natural source of primary odontoblasts that induce root
dentin formation while DPSCs appear to be the source
of replacement odontoblasts [18]. Considering that apical
papilla is a developing tissue recognized as a hidden niche
of early progenitor/stem cells, SCAP might be superior to
DPSCs for dental tissue regeneration [17, 18].
2.1.3. Stem Cells from Human Exfoliated Deciduous Teeth
(SHED). SHED were first isolated by Miura et al. from vital
pulp remnants of exfoliated deciduous teeth [19]. Although
analogous to DPSCs which represent a specific cell popula-
tion with proven capacity for self-renewal and multilineage
differentiation, SHED differ from DPSCs in the expression
of various surface epitopes and have demonstrated higher
levels of population doublings with faster proliferation than
DPSCs.These cells also exhibit greater in vitro differentiation
potential towards the osteogenic and adipogenic lineages
compared to DPSCs [20]. In vivo transplantation of SHED
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loaded on scaffolds/tooth slices into immunocompromised
mice has resulted in the formation of tissue that closely
resembles physiological dental pulp in cellular morphology
and histological architecture [21, 22]. An interesting finding
by a recent study demonstrated the capacity of SHED to
differentiate into angiogenic endothelium in addition to
functional odontoblasts [23].
2.1.4. Sorted Subpopulation of Dental Pulp Cells. Positive
or negative isolation strategy is normally adopted for the
selection of a specific, more homogeneous subpopulation of
MSCs with optimal phenotypes. Recently, these techniques
have also been reported in the fractionation of dental pulp
stem cells, designed to isolate subpopulations that possess
higher angiogenic and neurogenic potentials, both of which
contribute to pulp homeostasis [24]. In a canine pulp ampu-
tation model, autotransplantation of CD31−/CD146− side
population (SP) cells with type I and III collagen led to the
formation of pulp-like tissues with capillaries and neuronal
processes by day 14 [25]. In a canine pulpectomy model,
autotransplantation of both CD31−/CD146− SP cells and CD
105+ cells with stromal cell-derived factor-1 (SDF-1) success-
fully induced complete regeneration of pulp-like tissue with
vasculogenesis and neurogenesis within 14 days. This was
followed by further formation of a continuous dentin-like
structure along the dentinal wall of root canals [26, 27]. In
this study, while the autotransplantation of unfractionated
pulp cells also resulted in pulp-like tissue formation, these
had lesser volume and underwent faster mineralization after
transplantation when compared to fractionated dental pulp
stem cells. Thus the pertinent question that arises is whether
to use the sorted subpopulation or the unfractionated pulp
stem cells in dentin/pulp regeneration procedure. The fact
is that most of the published studies do not attempt to
isolate subpopulations of dental pulp cells but directly utilize
the whole heterogeneous cell population. Isolation of a
purified stem cell subpopulation is futile for achieving amore
homogeneous population. As soon as stem cells are isolated
and plated and start to proliferate, asymmetric cell divisions
will eventually lead to a mixed culture of stem cells and
transiently amplifying cells that are more committed, but
which are not true stem cells. Cell sorting appears not to be
a cost-efficient option since there is no compelling evidence
to suggest a vast improvement in facilitating dentin/pulp-like
tissue regeneration.
2.2. Stem Cells of Nondental Origin
2.2.1. Stem Cells from Bone Marrow and Adipose Tissue.
Given that the availability and quality of dental pulp tissue
sharply decline with age, nonodontogenic stem cells have
been investigated as alternative sources among which stem
cells harvested from bonemarrow and adipose tissue showed
greatest promise owing to their advantageous biological
properties and partially shared gene expression profile of
various growth factors, extracellular matrix (ECM) proteins,
and transcriptional regulators [28, 29]. Ishizaka and his
group isolated SP cells from pulp and adipose and bone
marrow tissue of the same individual dog, respectively, and
evaluated their complete pulp regeneration capacity using
a pulpectomized canine tooth model [30]. Noticeably, autol-
ogous transplantation of adipose and bone marrow CD31−
SP cells with SDF-1 yielded tissues that were morphologically
identical to that derived by transplanted pulp CD31− SP
cells and all three regenerated tissues possess functional
properties similar to normal pulp [30]. Consistent with
this finding, the mobilized stem cell subpopulation isolated
from canine bone marrow and adipose tissue utilizing
the granulocyte-colony stimulating factor (G-CSF) induced
chemotaxis method demonstrated the complete regeneration
of pulp-like connective tissues similar to pulp-derived cell
subpopulations, although less in amount, angiogenesis, and
reinnervation [31]. However, due to the inclusion of SDF-
1 which is implicated in hematopoietic stem cell homing to
the bone marrow niche via a CXC chemokine receptor-4
(CXCR4) dependent mechanism in the autotransplantation
procedure, the formation of pulp-like tissue in these studies
appears independent of the origin of implanted cells but was
more dependent on the microenvironment at the transplan-
tation sites [30]. Furthermore, connective tissue formation by
nondental cells does notmean that it is functional. Additional
evidence is needed to support the feasibility of using adipose
and bone marrow tissue-derived stem cells in dentin/pulp
regenerative therapies.
2.2.2. Induced Pluripotent Stem Cells (iPSCs). The generating
of induced pluripotent stem cells (iPSCs) is a groundbreaking
work that revolutionizes the present scenario of regenerative
medicine. This can be realized through reprograming adult
somatic cells or terminally differentiated cells back to a
pluripotent state via overexpression of four defined transcrip-
tion factors [32–34]. Analogous but superior to embryonic
stem cells, patient-specific iPSCs can give rise to all cell
lineages in the body, circumventing the clinical barriers
of immunological rejection or ethical controversy [33, 35].
Compared to other developmentally mature somatic cells
that require additional reprogramming factors, oral-derived
MSCs, DPSCs, SCAP, and SHED can be more easily repro-
grammed into iPSCs at higher efficiencies and are therefore a
more attractive alternative source for iPSCs generation [36].
Recently, an efficient induction protocol has been developed
to facilitate the differentiation ofmurine iPSCs (miPSCs) into
neural crest-like cells (NCLC) in vitro [37]. These NCLC fur-
ther demonstrated their potential to differentiate into dental
mesenchymal cells including odontoblasts upon coculture
with mouse dental epithelium. Furthermore, an in vivo study
demonstrated the formation of dentin-like and dental pulp-
like structures upon transplantation of the reconstructed
tooth germs derived from miPSCs together with epithelium
and mesenchyme into mouse subrenal capsule [38]. Despite
that, not all of the reconstituted tooth germs produced per-
fect tissue-engineered tooth-like structures.These interesting
findings demonstrate much potential of iPSCs in future
regenerative dentistry research.
3. A Call for Dental Stem Cell Banking System
When cell-based therapy is adopted for dentin/pulp tis-
sue regeneration, the procuring of a readily available stem
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cell source is of the highest priority. While the favorable
properties of low immunogenicity and immunosuppression
exhibited by oral-derived adult stem cells offer much pos-
sibility for allogeneic cell transplantation, these adult stem
cells will likely express histocompatibility antigens upon
differentiation and will thus not be able to sustain the
immunosuppressed state [39–41]. Hence, themajority of cell-
based approaches still prefer an autologous cellular source
for transplantation to best mitigate the risks of immunolog-
ical rejection and pathogenic transmission [42]. However,
autologous cell sources are often not necessarily off-the-
shelf at the time of treatment. The isolated small quantities
of mesenchymal-like stem cells from pulp tissue have to
undergo long and extensive processing prior to utilization in
transplanting procedure, which prompts the need for a well-
established “dental stem cell banking” system for cell isolation
and long-term storage. In recent decades, while increasing
numbers of private tooth banks have been established, none
of them provide clinical-grade MSCs due to a lack of afford-
able goodmanufacturing practice (GMP) compliant facilities
on the market [42, 43]. Before establishing a public dental
stem cell banking system, the state and quality of preserved
cells should be strictly evaluated and monitored because the
origin of stem cells varies and an array of confounding factors
such as donor-associated variability is likely to influence the
overall therapeutic efficacy.
3.1. Is Inflamed Dental Pulp Tissue Eligible? Conventionally,
infected or inflamed pulp tissue will be completely removed
by pulpectomy in order to create a sterile environment for the
subsequent restorative treatment. However, a considerable
portion of healthy and vital pulp tissue might also be
discarded as medical waste together with the necrotic dental
pulp. Recently various studies have reported successful isola-
tion of viable stem cells from inflamed dental pulp, but with
conflicting regenerative effects on dentin/pulp tissue. Yazid et
al. showed that MSCs obtained from primary inflamed pulp
exhibited highly dysfunctional MSCs stemness and minimal
immunoregulatory capacity [44]. By contrast, Pereira et al.
demonstrated that stem cells derived fromnormal pulp tissue
resembled that from inflamed pulp in morphological char-
acteristics, proliferation, and differentiation potentials [45].
Yu et al. reported that stem cells from normal and inflamed
pulp exhibited similar proliferation rates and multipotency
[46]. Using a severe combined immunodeficient mice model
(SCIDM), Alongi et al. observed that dentin/pulp-like com-
plexes formed by dental pulp stem cells from inflamed pulp
(DPSCs-IP) resembled the tissues formed by DPSCs from
normal pulp [47]. While inflammation has been identified
to facilitate odontoblastic differentiation and dentin matrix
formation, severe inflammation is known to induce cellular
apoptosis [48]. Although DPSC-IPs appears to be a more
readily available cell source, the therapeutic efficacy still
awaits being verified by further investigations and the risk of
pathogenic transmission from infected tissues arouses much
concern [47].
3.2. Does Donor’s Age Matter? The right time for banking
cells is a thought-provoking question. There seems to be
a noticeable progressive age-associated reduction in regen-
erative capacity of MSCs present in multiple adult organs
including teeth [49]. Molecular differences in cell popula-
tion of different ages have been detected with more robust
expression of genes implicated in cell stemness, mitosis, and
proliferation in deciduous teeth than in permanent teeth [50].
Conversely, mobilized DPSCs (MDPSCs) with granulocyte-
colony stimulating factor (G-CSF) derived from young dog
demonstrated similar proliferation, migration potential, and
antiapoptotic effects as well as similar expression levels
of genes encoded for trophic factors to that from aged
dog [51]. In that study, after autologous transplantation of
these two different age groups of canine MDPSCs into
pulpectomized teeth, pulp tissues produced by agedMDPSCs
demonstrated significantly retarded growth compared to
youngMDPSCs, indicating that it might not be MDPSCs per
se but the resident endogenousMSCs supported byMDPSCs-
derived trophic effects that contributed to the observed age-
dependent decline in pulp regenerative capacity [51]. When
comparing DPSCs obtained from third molars of patients
ranging from 12 to 30 years old, Kellner et al. concluded that
age appeared not to be a crucial determinant of the maximal
cell division potential and that donors ranging from 12 to 30
years old were all suitable groups for stem cell banking [52].
3.3. Considerations for Other Confounding Factors. In addi-
tion to the physical state of dental tissue, other general health-
associated parameters like smoking and nutrition are possible
factors that can influence the physiological activity of dental
pulp cells (DPCs) and overall biological properties of dental
pulp tissue, although the evidence is weak [53, 54].
4. Scaffold
A scaffold is one of the three essential components of classic
tissue engineering strategy. Functionally, scaffolds provide a
three-dimensional (3D) temporary structural framework for
cell seeding, adhesion, proliferation, and spatial distribution
until their complete replacement by the newly synthesized
matrix of endogenous host cells [55, 56]. Currently, the role
of an ideal scaffold is not limited to serving as a bioinert cell
delivery vehicle but extends to acting as a bioactive platform
regulating cellular activities and intracellular communica-
tion and thus to faithfully recapitulating their physiological
microenvironment-ECM.
Collagen, a major macromolecular constituent of dentin
ECM with excellent biocompatibility, is the most extensively
studied naturally occurring material for dental tissue engi-
neering. Comparison of different natural polymers including
collagen type I, collagen type III, chitosan, and gelatin
suggests that hDPCs plated on collagens, particularly type
I collagen, perform best in terms of proliferation and min-
eralization capacity [57]. Combined utilization of a collagen
scaffold carrying DPSCs and dentin matrix protein 1 (DMP1)
at a simulated furcal perforation site within dentin slice
resulted in apparent pulp-like tissue organization after trans-
plantation into a SCIDM [58]. A recent study demonstrated
the positive effects of collagen in supporting the survival
and odontogenic differentiation of SHED in vitro and also
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facilitating pulpal tissue regeneration in a full-length root
canal in vivo [59]. When cultured in a 3D-ECM-embedded
type I collagen/chitosan scaffold, the expressions of putative
odontogenic differentiation markers in DPSCs were upreg-
ulated with crystalline hydroxyapatite nucleation whereas
only amorphous calcium phosphate nucleation occurred
with DPSCs cultured in ECM-free scaffold. Furthermore,
formation of pulp-like tissue expressing dentin sialoprotein
(DSP) and dentin phosphophoryn (DPP) was detected in a
study after transplanting ECM scaffolds containing DPSCs
into SCIDM [60].
Synthetic materials such as polylactic acid (PLA), polyg-
lycolic acid (PGA), and their copolymer poly lactic-glycolic
acid (PLGA) have attained approval from the United States
Food and Drug Administration (FDA) for wide applica-
tion due to their nontoxic properties. An earlier study
demonstrated that PGA accelerated collagen deposition
and appeared to be more conducive to DPCs proliferation
compared to alginate or collagen scaffolds [61]. A highly
desirable outcome has been reported when using poly-D,L-
lactide/glycolide (PLG) scaffolds for delivery of SCAP and
DPSCs into target transplantation site. The results showed
de novo regeneration of vascularized pulp-like tissue in an
empty root canal space accompanied by deposition of dentin-
like tissues along dentinal walls formed by newly derived
odontoblast-like cells [62].
Platelet-rich plasma (PRP) and platelet-rich fibrin (PRF)
are other potential materials easily obtained from autologous
blood and thus can minimize the risk of adverse immuno-
logical response. These can release many vasculogenesis-
associated factors including vascular endothelial growth fac-
tor (VEGF), platelet-derived growth factor (PDGF), basic
fibroblast growth factor (bFGF), insulin-like growth factor-
1 (IGF-1), transforming growth factor-b 𝛽1 (TGF-b 𝛽1), and
TGF-b𝛽2, when platelets are activated [63, 64]. Recently, PRF
and PRP at appropriate concentrations have been demon-
strated to induce proliferation and accelerate mineralized
differentiation of DPSCs [63, 65].
In a nutshell, although both natural polymers and syn-
thetic materials have demonstrated promising therapeu-
tic effects on dentin/pulp regeneration, neither of them
embraces all the favorable properties that can recapitulate the
cellular physiological microenvironment. Natural polymers
are usually afflicted with issues of purity and antigenicity.
Synthetic polymers, albeit circumventing the potential risks
of immunoreactivity and being more readily amenable to
clinical applications with tailor-made physiochemical prop-
erties, still lack bioactive molecules present in native ECM
that are necessary for cellular recognition and interaction, in
addition to various technical challenges in regulating pore
sizes and achieving high porosity structures [66].
Recently, nanofibrous polymer scaffolds have been syn-
thesized to biomimic ECM in structure and function. They
appear superior to other scaffold materials at microstructural
level or other morphological arrangements owing to their
interconnected porous networks and advantages in high
surface area to volume ratio [4]. Most strikingly, nanofibrous
polymers can be tailor-made to facilitate specific cellular
behaviors and cell-ECM interaction [67, 68]. To date, only
three cutting-edge techniques are available for fabrication
of nanofibrous scaffolds, which are molecular electrospin-
ning, self-assembly, and thermally induced phase separation
(TIPS). Electrospinning process that involves the application
of a high voltage to a polymer solution ormelt loadedwithin a
needle orifice/syringe can generate continuous polymer fibers
with diameters varying from nanometers to micrometers
[69, 70]. The latest research milestone of electrospinning
technique lies in its new role as drug delivery vehicles rather
than a single cell carrier only. Interestingly, novel antibiotic-
containing nanofibrous scaffolds not only create a sterile
environment conducive to tissue survival and development
but tend to be more cell-friendly by minimizing toxic side
effects via controlled release of chemical agents at lower
concentrations [71, 72]. TIPS system refers to the induc-
tion of a homogenous polymer solution to separate into a
polymer-rich phase and a solvent-rich phase by lowering
the temperature to a critical point. TIPS has demonstrated
synergistic effects with other techniques to generate 3D
nanofibrous scaffolds with interconnected pore structures
that can facilitate cell infiltration, cell proliferation, nutrient
distribution, and tissue formation [73, 74]. The natural self-
assembly process, regarded as the spontaneous organization
of components into a particular structure, can be mimicked
and utilized to produce nanofibrous polymers from engi-
neered self-assembling peptides [67, 75]. Self-assembly at
the molecular level contributes to hydrogel formation which
has demonstrated unique cell encapsulation function and
superior capacity to promote cell adhesion, proliferation, and
differentiation [76–78].
5. Limitation of Cell Transplantation Strategy
in Preclinical Animal Models
Several preclinical animal models based either on ectopic or
on orthotropic transplantation approach have been devel-
oped to translate cell-based therapy into clinical reality.
Although a substantial body of evidence has confirmed the
regeneration of mineralized tissue, some studies still failed to
detect the presence of dentin-like tissue but instead found tis-
sues with bone-like morphology [79].This is likely attributed
to the differentmicroenvironment of the transplantation sites
in animal studies which appears to be a fourth element of
tissue engineering that influences the fate of stem/progenitor
cells in vivo. Comparisons of data extracted from different
studies suggest that the fate of implanted stem/progenitor
cells may be site-associated rather than being influenced
by their origin, with a tendency to differentiate into the
odontoblast phenotype when transplanted into the pulp
chamber but into other cell lineages when transplanted into
other target locations [80]. SCAP, a potential cell source
for in situ dentin/pulp regeneration, may be lost during
the transplantation process. It cannot be ruled out that
the quiescent host stem cells residing in the niche of the
transplantation site may be stimulated and recruited into
the regenerated construct together with pulp-derived stem
cells and thus pulp cell may lose its predominant effect
on tissue mineralization [80]. Additionally, in situ pulp
regeneration is often disadvantaged by ischemic conditions
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due to the constricted opening at the root apex allowing for
blood microcirculation while root fragments or tooth slices
rarely face this problem. Despite the deficiency of ectopic
models in mimicking the in situ tooth microenvironment in
clinical practice, the implementation of orthotropic model
encounters formidable challenges. After transplantation into
the pulpectomized teeth, the fabricated tissue replacement
has a tendency to adhere to the coronal portion of root canals,
leaving the middle and apical parts incompletely filled [78].
This is mainly due to the unique anatomical structure of
root canals, with progressively complex spatial patterns and
increased spatial pressure towards the apex, which in turn
constricts the placement and extension of any replacement. In
an animal study, Iohara et al. successfully initiated a complete
orthotopic pulp regeneration procedure in a dogmodel using
autologous pulp CD105+ cells. Two weeks after implantation
of CD105+ cells with stromal cell-derived factor-1 (SDF-1)
into pulpectomized caninemature teeth, pulp-like tissue with
vasculogenesis and neogenesis filled the empty root canal
space accompanied by the deposition of dentin-like structure
along the dentinal walls [26]. In addition, studies applying a
mixture of DPSCs and PRP to canine teeth after pulpectomy
demonstrated partial vital pulp regeneration even though
the typical structures in most cases have been identified as
periodontal-like tissue [81, 82].
6. Potential Strategies to Promote
Dentin/Pulp Regeneration
The critical requirements for successful dentin/pulp regener-
ation are not confined to the morphogenesis of dentin/pulp-
like tissue but should also be accompanied with angiogenesis
and neurogenesis. It must be noted that the deposited dentin-
like tissues on existing dentin structure are produced by
the newly differentiated odontoblasts from the dentinal wall
within the root canal space. Currently, potential strategies
dedicated to optimizing stem cell-mediated dentin/pulp
regeneration are directed towards two main objectives: firstly
angiogenesis induction and, secondly, the promotion of tissue
mineralization.
The long-term survival of tissue-engineered implants
largely depends on rapid establishment of adequate blood
supply at the graft sites which functions as a conduit
for nutrient transportation, oxygen delivery, and metabolic
waste excretion. This principle is particularly relevant to
dentin/pulp regeneration given that the opening at root apex
is too constricted to allow for intracanal blood infusion
[56]. Due to a delay in nutrition and oxygen support, the
therapeutic efficacy of stem cells during long-term engraft-
ment may be reduced dramatically and implanted cells may
ultimately enter into hypoxia-induced apoptosis. Conven-
tionally, it is routine to await the access and ingrowth of
new vasculature into the transplanted replacement within
the canal space. This approach, however, may be problematic
when fabricating a cell-dense thick construct which blocks
the diffusion of essential oxygen and nutrients. In addition,
it is highly probable that prior to their integration with
host tissue the bioengineered replacement grafts will suffer
from ischemia and thus undergo necrosis since the complete
establishment of host-derived vascular networks including
initial ECs migration, proliferation, angiogenic sprouting,
and final phase of vascular stabilization is quite a lengthy
process [83]. Prevascularization has emerged as a viable alter-
native strategy to address this challenge. With the assistance
of the vessel plexuses formed in advance, the bioengineered
grafts may more rapidly anastomose with the host-derived
vascular structure after transplantation. Several prevascu-
larization approaches in attempting to facilitate dentin/pulp
regeneration will subsequently be discussed in detail.
6.1. Hypoxia for Angiogenesis. Hypoxia is a common phe-
nomenon encountered by dental pulp tissue under both
pathological and nonpathological conditions. Due to their
unique anatomical structure that is surrounded by hard
dentin with only a narrow opening at root apices, DPCs are
typically susceptible to ischemia during traumatic injuries
when surrounding vascular bundles are severely ruptured
or during restorative treatment whereby local anesthetics
containing vasoconstrictors slow down the velocity of blood
microcirculation. Exposure to ischemia blocks the oxygen
influx transported by the blood stream and thus disrupts
the oxygen homeostasis of dental pulp [84]. In addition,
the progressive inflammatory reactions resulting from dental
caries usually increase intracanal pressure and thus force oxy-
gen out. Even under nonpathological conditions, the oxygen
tensionwithin the root canal space (approximately equivalent
to 3%) appears lower than that in ambient air where ex vivo
pulp cell culture and expansion are normally conducted. For
these reasons, some investigators have tried to simulate the
conditions of pulp hypoxia and explore howDPCs respond to
low oxygen levels. Amemiya et al. demonstrated that canine
DPCs under hypooxygenation conditions exhibited higher
formazan production and growth rate compared to pulp cells
incubated under normoxic conditions [84]. Subsequently, an
array of studies conducted on hDPCs reported that hDPCs
cultured under hypoxic conditions exhibited increased pro-
liferation rate, higher percentages of side populations, and
enhanced angiogenic potential as well as increased ery-
thropoietin expression in vitro than those incubated under
normoxic conditions [85, 86]. Lida et al. successfully applied
hypoxic conditions for isolation of hDPCs from inflamed
teeth of older patients and demonstrated their odontogenic
capacity both in vitro and in vivo [87]. Consistent with these
findings, a recent study demonstrated extensive vessel-like
networks being formed in SCAP-HUVEC coculture group
under hypoxic conditions and that the induced hypoxic
environment significantly upregulated the expression of HIF-
1𝛼, ephrinB2, and VEGF [83]. Collectively, hypoxia may be a
viable and efficacious approach to enhance the probability of
isolating living DPCs from damaged or aged pulp tissues and
to prime the angiogenic capacity ofDPSCs for pulp repair and
regeneration.
6.2. Combinatorial Cell Seeding. In recent years, many
research groups have succeeded in vascularizing artificial
tissue constructs via codelivery of ECs with MSCs of various
types. The significance of coculture system is based on
the speculation that intricate signaling cross talk may be
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established among heterogenous cell populations, possibly
regulated by direct cellular interaction or paracrine signal-
ing [88]. This hypothesis is also applicable to tooth germ
development during which reciprocal cross talk between
epithelium and mesenchyme orchestrates sequential cellular
activities including cell proliferation, differentiation, and
even overall homeostasis, all of which play a crucial role
in tooth morphogenesis [89, 90]. The original intention of
using coculture systems in pulp regenerative therapy appears
mainly to potentiate committed differentiation of DPSCs
towards the osteo/odontoblast lineage. So far, a wide variety
of cell candidates have been attempted in cocultivation with
DPSCs. The coculture of DPSCs with dental ECs enhanced
the odontoblastic differentiation of DPSCs, possibly via
paracrine signaling of BMP2 and BMP4 secreted by dental
ECs [91]. When cocultured with osteoblasts, expression of
osteogenic-related genes has been shown to be upregulated
with increased mineralization in DPSCs [92]. Recently, the
selection of cell types incorporated into coculture systems has
been driven by angiogenesis/vasculogenesis consideration
to a greater degree. The signaling events at the molecular
and cellular levels are tightly orchestrated by the interplay
between pericytes and ECs. Without the guidance of peri-
cytes, the furthermaturation of blood vessels will be impeded
and the established vascular structures will not be main-
tained. Previous studies demonstrated that DPSCs resided
in the microvascular niche of dental pulp tissue, which
was supported by the expression of 𝛼-smooth muscle actin
and several mesenchymal and endothelial cell markers by
perivascular cells [93]. Dissanayaka et al. initiated the direct
coculture of DPSCs and ECs in vitro and found that HUVECs
dramatically facilitated the osteogenic/odontogenic differen-
tiation of cocultured DPSCs compared with either DPSC-
alone or HUVEC-alone cultures. In turn, DPSCs stabilized
and increased the longevity of the preexisting HUVEC-
formed vasculature [94]. DPSCs have been identified to
be located adjacent to blood vessels like a sheath covering
HUVECs, analogous to the spatial relationship and inter-
action between pericytes and ECs [78, 94]. Consistent with
this finding, Janebodin et al. demonstrated the superiority of
coculture of ECswithmurineDPSCs in formingmoremature
ex vivo tubular-like networks than coculture of ECswith bone
marrow mesenchymal stem cells (BMMSCs). Interestingly,
this study not only proved the pericyte-like topography and
potential function of DPSCs but also identified that the
mechanism of DPSCs in angiogenic induction was VEGFR-
2 dependent [95]. Another in vitro study demonstrated that
coculture of SCAP and HUVEC under hypoxia enhanced
the formation of vessel-like structure with increased tubular
length and branching points and that the secretion of VEGF
by SCAP might be utilized by HUVECs [83]. Further in vivo
study implied that contribution of DPSCs to vascular mor-
phogenesis when coimplanted with HUVECs not only was
confined to the paracrine effects of secreted proangiogenic
factors like VEGF, but also involved cell migratory mech-
anisms and corresponding scaffold disruption [78]. While
promising, the combinatorial culture of pulp-derived stem
cells with HUVECs seems not applicable to clinical settings
due to the immune incompatibility involved in HUVECs
utilization. Therefore, potential alternatives like endothelial
progenitor cells (EPCs) and human dermal microvascular
endothelial cells (HDMEC) should be further investigated in
combination with pulp stem cells.
6.3. Scaffoldless Delivery Approach with Cell Sheet Technology
(CST). Conventionally, stem cells are combined with exoge-
nous scaffold materials to form a 3D engineered structure
before transplanting into target sites. However, in addition to
those biomaterial-associated problems, this well-recognized
technique has long been questioned due to the inadequate cell
migration and cell retention within the supporting scaffolds.
Above all, the aforementioned biomaterials are far from
being able to replicate the natural ECM or the surface of
implantable device. A decade ago, Iohara et al. pioneered
a 3D in vitro culture system specifically for DPCs [96].
Unlike commonly used protocols, this system intended to
harvest cell pellets or aggregates simply via one-step cen-
trifugation. Compared to themonolayer culture, significantly
higher ECM accumulation and odontogenic differentiation
were observed in the 3D pellet. After being treated with
rh-BMP2, the transplantation of DPCs pellet successfully
induced reparative dentin formation in amputated canine
tooth pulp [96]. Considering that the centrifugation step
may bring extra force to affect cellular behaviors, Syed-Picard
et al. engineered more advantageous 3D scaffoldless tissue
instead, by using a self-assembly system where cells could
arrange and control their preferred 3Dmicroenvironment all
by themselves. Following insertion into the canal space of
human tooth root segments, this 3D self-assembled construct
regenerated vascularized dental pulp-like tissue in SCIDM
[97].
Recently, a similar but different innovative “scaffold-free”
approach developed for regenerative medicine, designated as
“cell sheet technology” (CST), has become a popular topic of
active research in the field of periodontal tissue engineering
[98–100]. Superior to routine cell isolation methods utilizing
dissociative enzymes or mechanical forces, both of which
probably compromise cell viability, CST is a noninvasive
approach relying on a thermoresponsive polymeric material,
referred to as poly(N-isopropylacrylamide) (PIPAAm). Cells
plated on PIPAAm-treated surface can be detached as a con-
tiguous monolayer with intact structure and ECM compo-
nents simply by using a modest temperature drop [101, 102].
However, owing to the poor manipulability of cell sheets in a
narrow tubular space, the graft is prone to undergo necrosis
without adequate ECM deposition and nutrition acquisition.
Na et al.modified the cell sheet structure to amore flexible 3D
pellet system-cell sheet derived pellet (CSDP) and achieved
pulp-assembled tissue regeneration in an entire empty tooth
canal space after ectopic transplantation into SCIDM [103].
Despite promising results, additional comprehensive in situ
evaluation of scaffoldless delivery system is required in large
animal models.
6.4. Injectable Scaffold Delivery System. The introduction of
preengineered 3D tissue constructs into transplantation sites
requires a viable and effective delivery system. In general,
scaffold adopted for bone or another body tissue regeneration
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is often fabricated with a rigid structure in order to provide
sufficient physical support. Proof-of-principle transplanta-
tion experiments have provided valuable mechanistic infor-
mation for dentin/pulp regeneration when using relatively
rigid scaffolds like PLLA casts with tooth slices or fragments
to deliver pulp stem cells [104]. However, theoretically,
extra support is not necessarily required from engineered
replacement since the surrounding dentin alone can offer
adequate physical and structural support and the unique
complex anatomical structure of root canals—a narrow and
tapering shape from the coronal to apex—hampers the
insertion of stiff biomaterials. Furthermore, the implanted
pulp cells within the rigid scaffolds will encounter great
difficulty in attaching and penetrating into the dentinal walls,
which impedes the generation of functional odontoblasts and
production of new dentin. Encouragingly, self-assembly tech-
niques at the molecular level contribute to the formation of
an injectable polymer hydrogel that closely mimics the ECM
structure at the nanoscale level [105]. Similar to a living tissue,
the hydrogel possesses a higher water content and lower
interfacial tension with good consistency. Extra superiority
originates from its soft property, withminimal invasiveness to
the surrounding dentin or the canal structure. This hydrogel
created from multidomain peptides allows for engineered
constructs administered in a soft 3D matrix and delivery
into the root canal system by a syringe with a prolonged
duration of action. Galler et al. demonstrated that DPSCs
encapsulated in a self-assembled peptide hydrogel exhibited
higher survival rates, enhanced spreading, and migration
ability than nonbioactive gels. Upon incorporation of induc-
tive GFs within the scaffold, it was demonstrated that only
DPSCs encapsulated hydrogel replete with GFs expressed
dentin-specific markers and formed well-vascularized soft
connective tissue analogous to normal functional dental
pulp after ectopic transplantation [77]. Similar findings were
also reported when SHED were mixed with Puramatrix—a
commercially available peptide hydrogel—and injected into
full-length root canals or transplanted into immune-deficient
mice. Moreover, the microenvironment created by this type
of hydrogel at 0.15% concentration can stimulate not only
the survival, proliferation, and functionalization of DPSCs
but also the vascular morphogenesis of HUVECs [78]. This
novel type of delivery system, while highly promising, has
obvious flaws in lack of control over tissue formation and
development. Currently, efforts are devoted tomaking hydro-
gel photopolymerizable and researchers are still looking for
novel self-polymerizable biomaterials which are in the liquid
state but can be transformed into a rigid form once delivered
into the target sites [106].
6.5. Inductive Growth Factors. The lineage commitment and
differentiation of dental stem cells during dentin/pulp tissue
repair and regeneration markedly differ depending on mul-
tiple factors. Apart from their intrinsic gene expression and
epigenetic profiles, the cellular fate of dental pulp-derived
stem cells seemsmore likely to be determined by the bioactive
signaling molecules within the local microenvironment [107,
108]. Currently, a diverse array of inductive growth factors
have been identified implicated in important cellular events
during dentinogenesis and pulp tissue regeneration and they
are either (1) released from the degraded dentin matrix
[109] or (2) derived from the etched platelets within induced
blood clot during revitalization procedures or (3) artificially
synthesized in vitro and locally delivered into engineered
tissue.
Nakashima demonstrated recombinant human BMP2
and BMP4 (rh-BMP2, rh-BMP4) induced tubular dentin
and osteodentin formation on canine amputated tooth pulp
when cappedwith inactivated dentinmatrix [110, 111]. Studies
conducted by Casagrande et al. unequivocally demonstrated
that SHED seeded on EDTA-treated tooth slice/scaffolds
displayed stronger expression of putative odontoblastic dif-
ferentiation markers than the untreated group and indicated
dentin-derived BMP2 is required to induce odontolineage
differentiation of SHED [112]. VEGF is a prototypic proan-
giogenic factor and a potent ECs mitogen with profound
regulatory effects on signaling cascades implicated in angio-
genesis/vasculogenesis [113, 114]. The truncated human den-
tal pulps showed increased microvessel density and neo-
vascularization after treatment with rh-VEGF for 7 days
[115]. VEGF has been demonstrated to induce SHED into
angiogenic endothelium both in vitro and in vivo [23]. In
an in vitro study in which SCAP were cocultured with
HUVECs, VEGF secreted by SCAP were metabolized by
HUVECs to facilitate the formation of new vasculatures and
thematuration of sprouted capillary networks [83]. bFGF has
been demonstrated to regulate odontogenesis and is released
by dental pulp fibroblasts upon injury [116, 117]. It has been
revealed that bFGF potentiates proliferation and migration
of human DPCs (hDPCs) while it suppresses their ALPase
activity and mineralization [118]. Notably, the inhibiting
effect of bFGF on cytodifferentiation of hDPCs was relieved
when bFGF-pretreated hDPCs were in subsequent culture
without bFGF [118]. Recently, an in vivo study demonstrated
that bFGF increased the survivability of DPSCs seeded on
silk fibroin scaffold and resulted in the formation of pulp-
like tissue replete with vasculature formation and calcium
mineral deposition along the radicular dentinal wall after
transplantation into SCIDM [119]. However, despite these
promising outcomes, the selection of growth factors, the
variation in their dosage, and the time to deliver them into
target sites may exert entirely different biological effects on
cellular behaviors, ranging from induction to inhibition and
even cell apoptosis.
6.6. Gene Therapy. Loading scaffolds with bioactive drugs
or protein molecules intended for promoting dental tissue
regeneration has achieved favorable results [120]. Never-
theless, it is highly probable that the harsh conditions for
manufacturing scaffolds including extremes of pH, heat,
shear strength, and the introduction of toxic solvents might
compromise the bioactivity of any signaling molecules
incorporated within the scaffolds. While a novel technique
named “ultrapurified water freeze-drying” can overcome
these shortcomings and successfully regenerate tissue that
morphologically resembled normal dental pulp, the local
delivery of growth factors into root canals still remained
a challenging task considering the large dosages required
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and repeated administration due to their short active half-
life coupled with poor distribution [121]. Gene therapy,
a relatively new frontier of medicine, has emerged as a
viable and promising strategy that obviates the delivery of
exogenous molecules. With this approach, genes encoding
the desired signaling molecules including growth factors,
morphogens, transcription factors, and ECM molecules are
delivered by viral or nonviral vectors into target somatic cells
to induce a series of biological responses that contribute to
the regeneration of the target tissue. Yang and colleagues
successfully transfected rat STRO-1 selected DPSCs with the
human BMP-2 gene by utilizing adenoviral vectors. They
demonstrated that BMP-2-transfected DPSCs secreted BMP-
2 at a high level and underwent more effective induction
towards the odontoblast phenotype compared to nontrans-
fected cells and produced calcified ECM without external
addition of osteoinductive factors into the culture medium
[121]. Their subsequent in vivo study further confirmed the
efficacy of BMP-2 transfection therapy in potentiating tissue
mineralization within the regenerated construct in favor of
bone-like structure rather than dentin-like morphology [79].
However, a literature search found a lack of evidence in this
field and gene therapy has yet to prove its efficacy in rescuing
necrotic tooth pulp as part of dentin/pulp regenerative treat-
ment [56]. Additionally, potential health hazards still exist
due to the infective ability of viral vector systems although
they can bemodified to reduce their detrimental effects to the
host cell. There remains much to be accomplished including
the safety issues and the accurate control of gene delivery
prior to the approval by FDA of gene therapy for clinical
research in endodontic treatments.
7. Conclusion
Owing to the recent advances in the field of biomedicine,
tissue engineering, and material science, great progress has
been achieved in the development of regenerative endodon-
tics. We are now at a stage of paradigm shift in endodontic
treatment from traditional restoration to complete replace-
ment of the compromised dental pulp tissues which can be
realized by two scientifically meritorious approaches, cell
transplantation and cell mobilization, including revitaliza-
tion/revascularization procedure. While simple to operate,
the cell mobilization approach may not be suitable to tis-
sues with large size defects, especially in the circumstance
of de novo pulp regeneration in the full-length root. In
addition, cells trapped within fibrin clots during revital-
ization/revascularization have neither a definite origin nor
a predictable quantity and thus the phenotype of regen-
erated replacements filling in root canals cannot be well
characterized, leading to variations in overall therapeutic
efficacy. In comparison, cell transplantation based on the
utilization of themeticulous triad of classic tissue engineering
including stem cells, scaffolds, and signaling molecules has
achieved promising outcomes. This cell-based method is
capable of repairing tissue defects with an extensive size
[43, 122]. Despite these remarkable accomplishments, cell
transplantation strategy still faces significant challenges and
has not demonstrated being a clinically feasible mode of
treatment. The stem cell banking procedure involving cell
isolation, ex vivo cell manipulation, and ultimate shipping
back to practitioners is a rather time-consuming process and
the cost involved may be too excessive over relatively mature
alternative therapies like dental implants or RCT. During
the expansion period, cell senescence, loss of stemness,
and microbial contamination are likely to occur, leading to
biological deterioration and even cellular apoptosis. Worse
still, MSCs are prone to experience malignant genetic trans-
formation and thus arouse safety concern of tumorigenesis
[42]. If these barriers can be resolved, stem cell-mediated
transplantation would be a very much sought-after treatment
modality for dentin/pulp tissue regeneration.
To date, no randomized clinical controlled trials have
been conducted to compare the efficacy of cell mobilization
or cell transplantation therapy and traditional endodontic
treatment. Superior to tooth restoration, regenerative ther-
apy is considered as a potential solution to address the
deficiencies in tooth homeostasis, immune defense system,
blood supply, and functional dentin-pulp complex formation.
Moreover, it prolongs the life of natural dentition, defers the
extraction fate of teeth with partially necrotic pulp, and thus
ultimately improves the overall oral health-related quality
of life. Collectively, additional studies in these fields should
continue in order to work out a clinically translatable plat-
form on dentin/pulp regeneration. Future research prospects
in regenerative endodontics rely on the multidisciplinary
collaboration of clinicians, biomaterial scientists, and engi-
neers with expertise in their own fields and their joint con-
tributions to the development of dentin/pulp regeneration
therapy.
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